热门资讯> 正文
Alpha Cognition公开发行普通股定价3500万美元
2025-10-01 11:55
- Alpha Cognition (NASDAQ:ACOG) has priced its underwritten public offering of 5.6M common shares (or pre-funded warrants in lieu thereof), at $6.25 per share for gross proceeds of $35.0 million.
- The underwriter has a 30-day option to purchase up to an additional 840,000 common shares.
- The net proceeds will be used for the acceleration of commercial launch, with an emphasis on sales expansion, marketing investment, enhancing payer coverage, and reimbursement infrastructure. The company believes that the net proceeds will accelerate the commercialization of ZUNVEYL (Benzgalantamine), enabling them to capitalize on early commercial learnings.
- The offering will close on October 2, 2025.
- The company’s total cash position expected to be approximately $70 million following closing of the offering.
- ACOG --5.6% after hours to $6.14
- Source: Press Release
More on Alpha Cognition
- Alpha Cognition Inc. (ACOG) Q2 2025 Earnings Call Transcript
- Alpha Cognition: Unheralded Canadian Pharma Set To Launch Alzheimer's Drug
- Alpha Cognition announces proposed public offering of common shares
- Seeking Alpha’s Quant Rating on Alpha Cognition
- Historical earnings data for Alpha Cognition
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。